Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| POH | Bio International Convention Presentation - Atlanta, Georgia | 21/05/09 | ||
| POH | Retinoic Acid - Two-staged Phase 1 Clinical Trial | PRICE SENSITIVE | 30/04/09 | |
| POH | Annual Report-AGM documentation - Option Expiry Notice | 14/04/09 | ||
| POH | Becoming a substantial holder | 05/03/09 | ||
| POH | Successful Completion Phase 1 Diclofenac Study | PRICE SENSITIVE | 24/02/09 | |
| POH | Appendix 4E Preliminary Final Report inc Financial Report | PRICE SENSITIVE | 18/02/09 | |
| POH | Acquired Intangible Asset Valuation Review | PRICE SENSITIVE | 28/01/09 | |
| POH | Insulin Trial on Type 1 Diabetic Patients Completed | PRICE SENSITIVE | 06/01/09 | |
| POH | Positive Phase 1 Clinical Trial for Transdermal Lidocaine | PRICE SENSITIVE | 08/12/08 | |
| POHBio International Convention Presentation - Atlanta, Georgia | |||
| 21/05/09 | |||
| POHRetinoic Acid - Two-staged Phase 1 Clinical Trial | |||
| 30/04/09 | PRICE SENSITIVE | ||
| POHAnnual Report-AGM documentation - Option Expiry Notice | |||
| 14/04/09 | |||
| POHBecoming a substantial holder | |||
| 05/03/09 | |||
| POHSuccessful Completion Phase 1 Diclofenac Study | |||
| 24/02/09 | PRICE SENSITIVE | ||
| POHAppendix 4E Preliminary Final Report inc Financial Report | |||
| 18/02/09 | PRICE SENSITIVE | ||
| POHAcquired Intangible Asset Valuation Review | |||
| 28/01/09 | PRICE SENSITIVE | ||
| POHInsulin Trial on Type 1 Diabetic Patients Completed | |||
| 06/01/09 | PRICE SENSITIVE | ||
| POHPositive Phase 1 Clinical Trial for Transdermal Lidocaine | |||
| 08/12/08 | PRICE SENSITIVE | ||
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| POH (ASX) Chart |
Day chart unavailable
